Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
06 May 2025
| Name: | SIRTEX MEDICAL LIMITED (SRX) |
| Date of Listing: | 24 August 2000 |
| Date of Delisting: | 24 September 2018 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 24 September 2018.Legal Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
REGISTRY:
Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Tel : 61 1300 554 474
Fax : 02 9287 0303
RegistryWebsite RegistryEmail
delisted from the close of trading on Monday, 24 September 2018, pursuant to Listing rule 17.11. | 24/09/2018 |
we understand Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited acquired all of the shares in SRX for the cash consideration of A$33.60 per share | 24/09/2018 |
The scheme of arrangement by which Grand Pharma Sphere, an entity owned by CDH Genetech and China Grand Pharmaceutical and Healthcare Holdings would acquire all shares of Sirtex was implemented today. | 20/09/2018 |
The securities of Sirtex Medical Limited will be suspended from quotation at the close of trading today, Thursday, 13 September 2018, in accordance with Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited will acquire all of the issued shares in SRX. | 13/09/2018 |
listed entity carried for record purposes only | 01/07/2004 |
delisted from the close of trading on Monday, 24 September 2018, pursuant to Listing rule 17.11. | 24/09/2018 |
we understand Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited acquired all of the shares in SRX for the cash consideration of A$33.60 per share | 24/09/2018 |
The scheme of arrangement by which Grand Pharma Sphere, an entity owned by CDH Genetech and China Grand Pharmaceutical and Healthcare Holdings would acquire all shares of Sirtex was implemented today. | 20/09/2018 |
The securities of Sirtex Medical Limited will be suspended from quotation at the close of trading today, Thursday, 13 September 2018, in accordance with Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which Grand Pharma Sphere (Australia Bidco) Pty Ltd, an entity owned by CDH Genetech Limited and China Grand Pharmaceutical and Healthcare Holdings Limited will acquire all of the issued shares in SRX. | 13/09/2018 |
listed entity carried for record purposes only | 01/07/2004 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 25/08/2017 | Katherine Woodthorpe | 2,000 | $14.800 | $29,600 | |
| 23/08/2017 | Neville Mitchell | 6,000 | $14.566 | $87,397 | |
| 26/10/2016 | Gilman Wong | 74,968 | $28.484 | $2,135,378 | |
| 28/09/2015 | Richard Hill | On market | 3,000 | $33.438 | $100,314 |
| 19/07/2013 | Gilman Wong | On market | 30,106 | $11.848 | $356,684 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Nigel Lange | CEO | 13/01/2017 |
| Darren Smith | CFO, Company Secretary | 26/02/2009 |
| Neville Mitchell | Independent Director | 10/04/2017 |
| Katherine Woodthorpe | Independent Director | 22/09/2015 |
| Andrew McLean | Executive Director, CEO | 05/06/2017 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| John Eady | Non Exec Chairman | 01/03/2005 | 20/09/2018 |
| Helen Kurincic | Independent Director | 13/09/2017 | 20/09/2018 |
| Grant Boyce | Non Exec Director | 19/12/2002 | 20/09/2018 |
| Richard Hill | Non Exec Chairman, Independent Director | 01/09/2004 | 28/10/2017 |
| Gilman Wong | CEO, Director | 01/03/2005 | 13/01/2017 |
| Bruce Gray | Non Exec Director | 01/04/1997 | 23/01/2007 |
| Charles Rowland | Executive Director, Executive | 28/06/2003 | 26/10/2005 |
| Michael Panaccio | Non Exec Director | 01/02/1998 | 29/07/2005 |
| Colin Sutton | CEO | 01/03/2000 | 30/06/2003 |
| Christopher Roberts | Non Exec Chairman | 01/03/2000 | 19/12/2002 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
